Growth Metrics

Oculis Holding AG (OCS) Net Income Growth (1y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 12.59%
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -115.51%
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -290.15%
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 59.59%
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -10.08%
8 Evaxion A 65.12 Bn 65.10 Bn - -73.01%
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 1,228.66%
10 Oculis Holding AG 24.51 Bn 24.21 Bn - -0.46%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.46%
Dec 31, 2025 318.67%
Sep 30, 2025 9.56%
Jun 30, 2025 -33.65%
Mar 31, 2025 -101.02%
Dec 31, 2024 -135.51%
Sep 30, 2024 -116,344.35%
Jun 30, 2024 -63.33%
Mar 31, 2024 62.88%
Dec 31, 2023 -47.68%
Sep 30, 2023 -94.05%
Jun 30, 2023 -10.51%